Skip to Main Content

Paper Details

Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network.
Influenza Other Respir Viruses
6
2023
ARI, COVID, COVID-19, Delta, NP, Omicron, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 nucleocapsid, acute respiratory illness, immunoglobulin-G antibodies, mRNA, participants, patients, spike protein receptor binding domain
Author NameAffiliation
Karen J WernliKaiser Permanente Washington Health Research Institute
Karen J WernliKaiser Permanente Washington Health Research Institute
Emily T MartinUniversity of Michigan School of Public Health ann arbor
Edward A BelongiaMarshfield Clinic Research Institute
Manjusha Gaglani
Manjusha GaglaniTexas A&M University College of Medicine
Richard K ZimmermanUniversity of Pittsburgh
Helen K B TalbotVanderbilt University Medical Center
Natalie J ThornburgCenters for Disease Control and Prevention
Brendan FlanneryCenters for Disease Control and Prevention
  • 1 - 10

Datasets

Release 1.2